CAPRICOR THERAPEUTICS, INC. Additional Paid in Capital, Common Stock
CAPRICOR THERAPEUTICS, INC. (CAPR) had Additional Paid in Capital, Common Stock of $625.88 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AdditionalPaidInCapitalCommonStock · last filed 2026-08-14
- 2026-06-30: Additional Paid in Capital, Common Stock $625.88M.
- 2026-03-31: Additional Paid in Capital, Common Stock $617.72M.
- 2025-12-31: Additional Paid in Capital, Common Stock $610.33M.
- 2025-09-30: Additional Paid in Capital, Common Stock $357.68M.
| Period end | Additional Paid in Capital, Common Stock | Additional Paid in Capital, Common Stock as first filed |
|---|---|---|
| 2026-06-30 | $625.88M 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $617.72M 10-Q · filed 2026-05-13 | |
| 2025-12-31 | $610.33M 10-Q · filed 2026-08-14 | |
| 2025-09-30 | $357.68M 10-Q · filed 2025-11-10 | |
| 2025-06-30 | $353.68M 10-Q · filed 2025-08-11 | |
| 2025-03-31 | $350.01M 10-Q · filed 2025-05-14 | |
| 2024-12-31 | $344.22M 10-K · filed 2026-03-17 | |
| 2024-09-30 | $260.85M 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $191.48M 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $187.26M 10-Q · filed 2024-05-14 | |
| 2023-12-31 | $181.70M 10-K · filed 2025-03-26 | |
| 2023-09-30 | $156.68M 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $154.74M 10-Q · filed 2023-08-08 | |
| 2023-03-31 | $150.93M 10-Q · filed 2023-05-12 | |
| 2022-12-31 | $148.74M 10-K · filed 2024-03-11 | |
| 2022-09-30 | $144.64M 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $141.67M 10-Q · filed 2022-08-12 | |
| 2022-03-31 | $140.50M 10-Q · filed 2022-05-11 | |
| 2021-12-31 | $139.40M 10-K · filed 2023-03-17 | |
| 2021-09-30 | $138.58M 10-Q · filed 2021-11-12 | |
| 2021-06-30 | $131.30M 10-Q · filed 2021-08-13 | |
| 2021-03-31 | $129.55M 10-Q · filed 2021-05-14 | |
| 2020-12-31 | $116.22M 10-K · filed 2022-03-11 | |
| 2020-09-30 | $114.25M 10-Q · filed 2020-11-13 | |
| 2020-06-30 | $111.58M 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $86.05M 10-Q · filed 2020-05-15 | |
| 2019-12-31 | $81.22M 10-K · filed 2021-03-15 | |
| 2019-09-30 | $76.48M 10-Q · filed 2019-11-08 | |
| 2019-06-30 | $73.67M 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $72.96M 10-Q · filed 2019-05-14 | |
| 2018-12-31 | $71.34M 10-K · filed 2020-03-27 | $71.31M 10-K · filed 2019-03-29 |
| 2018-09-30 | $70.41M 10-Q · filed 2018-11-14 | |
| 2018-06-30 | $68.93M 10-Q · filed 2018-08-13 | |
| 2018-03-31 | $65.71M 10-Q · filed 2018-05-14 | |
| 2017-12-31 | $62.74M 10-K · filed 2019-03-29 | |
| 2017-09-30 | $59.55M 10-Q · filed 2017-11-14 | |
| 2017-06-30 | $54.50M 10-Q · filed 2017-08-14 | |
| 2017-03-31 | $50.42M 10-Q · filed 2017-05-15 | |
| 2016-12-31 | $49.95M 10-K · filed 2018-03-22 | |
| 2016-09-30 | $49.49M 10-Q · filed 2016-11-14 | |
| 2016-06-30 | $38.99M 10-Q · filed 2016-08-15 | |
| 2016-03-31 | $38.33M 10-Q · filed 2016-05-13 | |
| 2015-12-31 | $34.12M 10-K · filed 2017-03-16 | |
| 2015-09-30 | $33.72M 10-Q · filed 2015-11-13 | |
| 2015-06-30 | $33.45M 10-Q · filed 2015-08-14 | |
| 2015-03-31 | $33.10M 10-Q · filed 2015-05-13 | |
| 2014-12-31 | $16.05M 10-K · filed 2016-03-30 | |
| 2014-09-30 | $15.91M 10-Q · filed 2014-11-14 | |
| 2014-06-30 | $15.75M 10-Q · filed 2014-08-14 | |
| 2013-12-31 | $15.55M 10-K · filed 2015-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |